StonvexLoading…
StonvexStonvexStonvexCore line items from LMRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 |
|---|---|---|
Revenue | $252.54M | $245.00M |
Operating Income | $19.41M | $25.54M |
Net Income | $1.72M | $-7.69M |
EPS (Diluted) | $0.02 | $-0.11 |
Total Assets | $1.76B | Not available |
Total Liabilities | $1.16B | Not available |
Cash & Equivalents | $51.23M | $7.30M |
Free Cash Flow OCF − CapEx | $-2.38M | $-14.96M |
Shares Outstanding | 96.08M | 69.52M |